Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl

The standard of care for benign pheochromocytomas and paragangliomas is surgical resection; however, there is no definitive curative or standard therapy for the treatment of malignant pheochromocytomas or paragangliomas. Current therapeutic options include surgical resection, chemotherapy (CVD thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Shindorf, Mackenzie L., Chaudhuri, Prabir K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748205/
https://www.ncbi.nlm.nih.gov/pubmed/31582983
http://dx.doi.org/10.1155/2019/7185973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748205/
https://www.ncbi.nlm.nih.gov/pubmed/31582983
http://dx.doi.org/10.1155/2019/7185973

Ejemplares similares